A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

Researchers used ArteraAI to identify 25% of prostate cancer patients in a large trial cohort for whom abiraterone halved the ...

The test, developed by Artera, uses AI to pick up features invisible to the human eye on images of tumour samples.

What are the stakes when a fraction of a second, the length of an extended arm or the weight of a body in motion can mean the ...

A postcode lottery means the £77-a-month drug is available to certain patients in Scotland and Wales, but not in England.

AI could eliminate the "postcode lottery" surrounding a life-extending treatment for advanced prostate cancer, researchers ...

Once thought to be a condition affecting only older men, erectile dysfunction is increasingly impacting men in their 20s and ...

Practice-changing research shows that a combination of androgen deprivation therapy -- a commonly used hormone injection ... U.S., affecting 1 in every 6 to 7 men. While there are rarely ...

The new AI test, built by a team from the US, UK and Switzerland, shows which men would most likely benefit from abiraterone.

Discover how hormonal imbalances create anxiety symptoms. Thyroid, cortisol, and blood sugar issues mimic panic disorders.

PROSTATE cancer is the most common cancer in men worldwide. This week, former US president Joe Biden revealed he has an ...

Prostate cancer is the fourth most common cancer among men in India. Often symptomless in its early stages, it is highly ...